ACN
65
4
MHK
40
-6
WEC
45
9
LYB
32
2
GE
65
-2
AVB
72
3
DNB
36
2
UNP
50
4
AMG
44
-3
VLO
33
-5
CRM
59
4
EFX
55
-2
BF.B
53
5
RHI
43
15
GOOGL
67
3
SNA
53
-3
JNPR
56
2
NDAQ
48
3
AIV
60
3
OXY
41
4
ACN
65
4
MHK
40
-6
WEC
45
9
LYB
32
2
GE
65
-2
AVB
72
3
DNB
36
2
UNP
50
4
AMG
44
-3
VLO
33
-5
CRM
59
4
EFX
55
-2
BF.B
53
5
RHI
43
15
GOOGL
67
3
SNA
53
-3
JNPR
56
2
NDAQ
48
3
AIV
60
3
OXY
41
4
Financhill
Back

Nike Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
46

NKE
Nike

Last Price:
97.13
Seasonality Move:
3.77%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
46
Nike (NKE) is a Sell

Is Nike a Buy, Sell or Hold?

  • The current Nike [NKE] share price is $97.18. The Score for NKE is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NKE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NKE Stock Price Chart

What is Nike's stock price today?

  • The Nike share price today is $97.18
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKE is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

NKE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.66 Buy
Relative Strength Index (14 RSI): 62.17 Buy
Chaikin Money Flow: 14457151 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (92.22 - 95.6) Buy
Bollinger Bands (100): (91.62 - 101.44) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

NKE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 94.96 Buy
20-day SMA: 94.34 Buy
50-day SMA: 93.55 Buy
200-day SMA: 100.37 Sell
8-day EMA: 95.34 Buy
20-day EMA: 94.58 Buy
50-day EMA: 94.51 Buy
200-day EMA: 100.17 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Nike Earnings Growth & NKE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.01 per share, an increase this year of $0.47 per share, and an increase next year of $0.16 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Nike Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):